Trial
NCT02962804
Combination Radiation and PD-1 Inhibition in Metastatic or Recurrent Renal Cell Carcinoma (RCC)
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Kansas Medical Center
Collaborators
—
Condition
Carcinoma, Renal Cell
Intervention
Nivolumab
Why stopped
Due to competing trials. Stopped before IRB approval.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2018-03-05